Literature DB >> 29740666

[Paradigm shift in urology : Prostate cancer diagnosis using MRI-targeted or standard transrectal ultrasonography-guided biopsy].

B Hadaschik1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29740666     DOI： 10.1007/s00120-018-0668-5

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  6 in total

1.  Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.

Authors:  Jan Philipp Radtke; Manuel Wiesenfarth; Claudia Kesch; Martin T Freitag; Celine D Alt; Kamil Celik; Florian Distler; Wilfried Roth; Kathrin Wieczorek; Christian Stock; Stefan Duensing; Matthias C Roethke; Dogu Teber; Heinz-Peter Schlemmer; Markus Hohenfellner; David Bonekamp; Boris A Hadaschik
Journal:  Eur Urol       Date:  2017-04-08       Impact factor: 20.096

Review 2.  Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.

Authors:  Massimo Valerio; Ian Donaldson; Mark Emberton; Behfar Ehdaie; Boris A Hadaschik; Leonard S Marks; Pierre Mozer; Ardeshir R Rastinehad; Hashim U Ahmed
Journal:  Eur Urol       Date:  2014-11-01       Impact factor: 20.096

3.  Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patients.

Authors:  Angelika Borkowetz; Boris Hadaschik; Ivan Platzek; Marieta Toma; Georgi Torsev; Theresa Renner; Roman Herout; Martin Baunacke; Michael Laniado; Gustavo Baretton; Jan Philipp Radtke; Claudia Kesch; Markus Hohenfellner; Michael Froehner; Heinz-Peter Schlemmer; Manfred Wirth; Stefan Zastrow
Journal:  BJU Int       Date:  2017-10-15       Impact factor: 5.588

4.  Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2 in clinically relevant prostate cancer.

Authors:  Jing Wang; Chen-Jiang Wu; Mei-Ling Bao; Jing Zhang; Xiao-Ning Wang; Yu-Dong Zhang
Journal:  Eur Radiol       Date:  2017-04-03       Impact factor: 5.315

5.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

6.  Pragmatic Trials.

Authors:  Ian Ford; John Norrie
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245
  6 in total
  2 in total

Review 1.  [Predictive biomarkers in oncologic uropathology].

Authors:  H Reis; T Szarvas; V Grünwald
Journal:  Pathologe       Date:  2019-05       Impact factor: 1.011

2.  Feasibility of diffusion weighting with a local inside-out nonlinear gradient coil for prostate MRI.

Authors:  Enamul Hoque Bhuiyan; Andrew Dewdney; Jeffrey Weinreb; Gigi Galiana
Journal:  Med Phys       Date:  2021-09-24       Impact factor: 4.506
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.